Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''
Digestive and Liver Disease · 2026-11
DOI: 10.1016/j.dld.2026.10.034 ↗Kurz gefasst
Leserbrief in der Zeitschrift Digestive and Liver Disease, 2026-11. Verfasst von Mohamed Moussa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Electronic address: m.moussa@erasmu…. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Electronic address: m.moussa@erasmusmc.nl.
- Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Zitieren
APA
Moussa, M., Sprengers, D., & Sonneveld, M. J. (2026). Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.10.034
Vancouver
Moussa M, Sprengers D, Sonneveld MJ. Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.10.034
BibTeX
@article{Moussa2026,
author = {Moussa, Mohamed and Sprengers, Dave and Sonneveld, M J},
title = {Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''},
journal = {Digestive and Liver Disease},
year = {2026},
doi = {10.1016/j.dld.2026.10.034}
}
EUVIMED